We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-5.97%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.6B
AUM Growth
-$228M
Cap. Flow
+$864M
Cap. Flow %
6.34%
Top 10 Hldgs %
11.84%
Holding
3,164
New
256
Increased
959
Reduced
778
Closed
260

Top Sells

Rank Stock Value
1
M icon
Macy's
M
+$55.7M
2
GLW icon
Corning
GLW
+$49.4M
3
LUV icon
Southwest Airlines
LUV
+$36.6M
4
TXN icon
Texas Instruments
TXN
+$34.1M
5
EBAY icon
eBay
EBAY
+$34M

Sector Composition

Rank Sector Weight
1 Technology 15.4%
2 Healthcare 14.04%
3 Financials 12.22%
4 Industrials 11.09%
5 Consumer Discretionary 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPR
476
DELISTED
Express, Inc.
EXPR
$3.02M 0.02%
8,457
+13
+0.2% +$4.89K
HEDJ icon
477
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.82B
$3M 0.02%
109,870
+57,450
+110% +$1.73M
LRCX icon
478
Lam Research
LRCX
$355B
$2.98M 0.02%
457,000
-110,320
-19% -$808K
LNC icon
479
Lincoln National
LNC
$7.87B
$2.96M 0.02%
62,434
-90,659
-59% -$4.86M
DAN icon
480
Dana Inc
DAN
$2.91B
$2.96M 0.02%
186,265
+10,265
+6% +$186K
STT icon
481
State Street
STT
$50.3B
$2.93M 0.02%
43,678
-441
-1% -$32.8K
IWS icon
482
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$2.92M 0.02%
43,544
+784
+2% +$55.7K
RL icon
483
Ralph Lauren
RL
$22.5B
$2.92M 0.02%
24,689
+23,869
+2,911% +$2.83M
KEY icon
484
KeyCorp
KEY
$24B
$2.91M 0.02%
223,967
+26,323
+13% +$374K
CRL icon
485
Charles River Laboratories
CRL
$10.8B
$2.9M 0.02%
45,714
+7,027
+18% +$505K
SCLN
486
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$2.86M 0.02%
412,166
+52,926
+15% +$453K
G icon
487
Genpact
G
$5.53B
$2.85M 0.02%
120,698
+8,170
+7% +$183K
IWO icon
488
iShares Russell 2000 Growth ETF
IWO
$14.4B
$2.83M 0.02%
21,150
-248
-1% -$36.7K
REXMY
489
DELISTED
REXAM PLC ADR - NEW
REXMY
$2.82M 0.02%
71,267
+38,333
+116% +$1.52M
JLL icon
490
Jones Lang LaSalle
JLL
$15.3B
$2.82M 0.02%
19,613
+747
+4% +$122K
KHC icon
491
Kraft Heinz
KHC
$31.2B
$2.82M 0.02%
+39,921
New +$3.01M
KUB
492
DELISTED
KUBOTA CORPORATION (ONE ADS REP 5 SHS COM)
KUB
$2.8M 0.02%
41,089
+15,687
+62% +$1.07M
CMCSK
493
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$2.8M 0.02%
49,012
-6,653
-12% -$381K
GEL icon
494
Genesis Energy
GEL
$1.81B
$2.79M 0.02%
72,745
+7,584
+12% +$327K
COF icon
495
Capital One
COF
$126B
$2.79M 0.02%
38,440
-2,554
-6% -$205K
JAH
496
DELISTED
JARDEN CORPORATION
JAH
$2.78M 0.02%
56,981
+9,943
+21% +$526K
EIX icon
497
Edison International
EIX
$30.3B
$2.77M 0.02%
43,914
+39,417
+877% +$2.34M
BP icon
498
BP
BP
$110B
$2.74M 0.02%
106,734
-15,338
-13% -$450K
VUG icon
499
Vanguard Growth ETF
VUG
$215B
$2.71M 0.02%
162,114
-12,030
-7% -$213K
DCM
500
DELISTED
NTT DOCOMO, Inc.
DCM
$2.69M 0.02%
159,727
+59,420
+59% +$1.19M

Similar funds

Glenmede Trust's Q3 2015 Portfolio in Review

As of Q3 2015, Glenmede Trust held 3,164 positions worth $13.6B, down 1.6% from $13.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Glenmede Trust deployed $864M of net new capital in Q3 2015, opening 256 new positions and adding to 959 existing holdings. Its largest new stake was PayPal: 1,978,444 shares worth $61.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Macy's, an estimated $55.7M trimmed.

  • Glenmede Trust's largest Q3 2015 buy was PayPal: 1,978,444 shares worth $61.4M.
  • Glenmede Trust added most to Omnicom Group in Q3 2015, an estimated $59.3M increase.
  • Glenmede Trust's biggest Q3 2015 reduction was Macy's, cutting an estimated $55.7M.
  • Glenmede Trust fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015, selling an estimated $18.8M.
  • Glenmede Trust's ten largest holdings make up 12% of its $13.6B portfolio in Q3 2015.
  • Glenmede Trust opened 256 new positions and closed 260 in Q3 2015.
  • Glenmede Trust's portfolio value fell 1.6% quarter-over-quarter to $13.6B.

Based on Glenmede Trust's 13F filing for Q3 2015, filed 12 Nov 2015.